1. Mitochondrial transplantation for cardioprotection and induction of angiogenesis in ischemic heart disease.
- Author
-
Hassanpour P, Sadeghsoltani F, Saghebasl S, Boroumand S, Khanicheragh P, Tafti SHA, Rahbarghazi R, and Rahmati M
- Subjects
- Humans, Animals, Mitochondria metabolism, Mitochondria, Heart metabolism, Myocardium metabolism, Myocardium pathology, Angiogenesis, Myocardial Ischemia therapy, Myocardial Ischemia pathology, Myocardial Ischemia metabolism, Neovascularization, Physiologic
- Abstract
To date, the regenerative potential of mitochondrial transplantation (MT) has been extensively investigated under several pathologies. Among various cardiovascular diseases, ischemic heart disease (IHD), the most prevalent pathological condition in human medicine, is induced by coronary artery narrowing, or occlusion, leading to bulk necrotic changes and fibrosis within the myocardium. Data associated with the pro-angiogenic activity of mitochondria have not been completely elucidated in terms of cardiac tissue regeneration. Here, we aimed to highlight the recent studies and advantages related to the application of mitochondrial mass in the ischemic myocardium. How and by which mechanisms, mitochondria can reduce aberrant myocardial tissue remodeling via different pathways such as angiogenesis and de novo blood formation was discussed in detail. We hope that data from the current review article help us understand the molecular and cellular mechanisms by which transplanted mitochondria exert their regenerative properties in the ischemic myocardium., Competing Interests: Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests., (© 2025. The Author(s).)
- Published
- 2025
- Full Text
- View/download PDF